按產品類型、最終用戶和地區分類的視覺障礙市場

2025 年全球視力障礙市場規模估計為 52.4 億美元，預計到 2032 年將達到 95.9 億美元，2025 年至 2032 年的複合年成長率為 9.0%。

數字。 2025 年各地區視力障礙市場佔有率（%）

預計全球視力障礙市場將在 2025 年至 2032 年間實現強勁成長。視力障礙是由於疾病、殘疾或傷害導致的視力限制，無法透過眼鏡等正常方式矯正。視力障礙的常見原因包括白內障、青光眼、老齡化黃斑部病變和糖尿病視網膜病變。世界人口快速老化、糖尿病盛行率上升和都市化是推動全球視力障礙市場發展的關鍵因素。然而，治療費用高以及農村地區認知度低阻礙了市場的成長。幹細胞療法和基因療法等治療領域的新創新在治療傳統方法無法解決的疾病方面顯示出良好的前景，從而開闢了新的途徑。

市場動態

全球視力障礙市場的發展受到易患眼科疾病的老年人口快速增加的推動。根據聯合國預測，到2050年，60歲以上人口預計將增加一倍以上，達到近21億人。糖尿病盛行率的上升也刺激了市場的發展。根據國際糖尿病聯盟統計，2020年全球9.3%的成年人口患有糖尿病，預計到2045年這數字將上升到10.9%。都市化和過度使用數位設備等不健康的生活習慣會為眼睛帶來疲勞，增加近視的風險，尤其是在年輕人中。然而，先進治療的成本高、偏遠地區醫療服務機會有限以及認知度低阻礙了市場的成長。幹細胞和基因療法的發展為治療傳統方法無法解決的慢性眼部疾病提供了有利可圖的機會。

研究的主要特點

• 本報告對全球視力障礙市場進行了詳細分析，並以 2024 年為基準年，給出了預測期（2025-2032 年）的市場規模（十億美元）和年複合成長率（CAGR%）。
• 它還強調了各個領域的潛在商機並說明了該市場的有吸引力的投資提案矩陣。
• 它還提供了關於市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的主要考察。
• 全球視力障礙市場的主要企業是根據公司亮點、產品系列、關鍵亮點、績效和策略等參數列出的。
• 本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
• 本研究報告針對該產業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
• 相關人員將透過全球視力障礙市場分析中使用的各種策略矩陣更輕鬆地做出決策。

目錄

第1章 調查目的與前提條件

• 研究目標
• 先決條件
• 簡稱

第2章 市場展望

• 報告描述
  • 市場定義和範圍
• 執行摘要
• 一致的機會圖 (COM)

第3章市場動態、法規與趨勢分析

• 市場動態
  • 驅動程式
  • 限制因素
  • 機會
• 影響分析
• 市場趨勢
• 監管情景
• 收購和合作場景
• 資金籌措和投資
• PEST分析
• 波特的分析

第4章 全球視覺障礙市場-冠狀病毒（COVID-19）大流行的影響

• 整體影響
• 政府舉措
• COVID-19 市場影響

5. 2020 年至 2032 年全球視力障礙市場（按產品類型分類）（十億美元）

• 介紹
• 教育設備和軟體
• 點字影印機及點字書寫機
• 點字電腦
• 數學和科學設備
• 點讀機
• 其他
• 行動裝置
• 甘蔗
• 其他
• 低視力設備
• 智慧眼鏡
• 船舶交通管理系統鏈接
• 放大鏡
• 其他
• 其他

6. 2020 年至 2032 年全球視力障礙市場（按最終用戶分類）（十億美元）

• 介紹
• 盲人學校及培訓設施
• 企業和社會組織
• 個人使用
• 醫院
• 其他

7. 2020 年至 2032 年全球視力障礙市場（按地區分類）（單位：十億美元）

• 介紹
• 北美洲
• 拉丁美洲
• 歐洲
• 亞太地區
• 中東
• 非洲

第8章 競爭格局

• 公司簡介
  • OrCam Technologies
  • Sangamo Therapeutics, Inc.
  • Freedom Scientific, Inc.
  • HumanWare Group
  • Enhanced Vision Systems（EVS）
  • Vispero
  • Eschenbach Optik GmbH
  • LVI Low Vision International
  • eSight Corporation
  • IrisVision
  • Rejoin Technology Co., Ltd
  • Zoomax Technology Co., Limited
  • Dolphin Computer Access Ltd
  • Aumed Group Corp.
  • Topcon Corporation
  • Microsoft Corporation
  • NovaVision, Inc.
  • Telesensory Corporation
  • Second Sight Medical Products, Inc.

第 9 章 興衰

• 興衰
• 一致的機會地圖

第10章參考文獻與調查方法

• 參考
• 調查方法

Global Visual Impairment Market is estimated to be valued at USD 5.24 Bn in 2025 and is expected to reach USD 9.59 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.0% from 2025 to 2032.

Figure. Visual Impairment Market Share (%), By Region 2025

Global visual impairment market is projected to witness robust growth during 2025-2032. Visual impairment refers to a limitation in the ability to see caused due to diseases, disorders, or injuries which cannot be corrected by usual means like glasses. Some common causes of visual impairment include cataracts, glaucoma, age-related macular degeneration, and diabetic retinopathy among others. Rapidly aging global population, rising prevalence of diabetes, and urbanization are the key factors driving the global visual impairment market. However, high cost of treatment and lack of awareness in rural areas hinders the market growth. New innovations in treatments like stem cell therapy and gene therapy holds promise to treat conditions not addressable by conventional methods, thereby opening new avenues.

Market Dynamics:

The global visual impairment market is driven by the rapidly growing geriatric population which are more prone to eye diseases. As per UN, United Nations the number of people aged 60 years and older is expected to more than double by 2050 and reach nearly 2.1 billion. Rising prevalence of diabetes also fuels the market. According to IDF, 9.3% of the global adult population had diabetes in 2020 and it is projected to rise to 10.9% by 2045. Urbanization leads to unhealthy lifestyle habits like the overuse of digital devices which strains eyes and increases risk of myopia especially among the younger population. However, high cost of advanced treatments, limited healthcare access in remote areas, and lack of awareness hinders the market growth. Development of stem cell therapy and gene therapy to treat chronic eye conditions not addressable by traditional methods offers lucrative opportunities.

Key Features of the Study:

• This report provides in-depth analysis of the global visual impairment market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global visual impairment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Novartis AG, Bausch Health Companies Inc., Acucela Inc., Nicox SA, Santen Pharmaceutical Co. Ltd., Allergan, and F. Hoffmann-La Roche AG
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global visual impairment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global visual impairment market

Detailed Segmentation-

• By Product Type
  • Educational Devices & Software:
  • Braille Duplicators and Writers
  • Braille Computers
  • Mathematical & Science Devices
  • Reading Machines
  • Others
  • Mobility Devices
  • Canes
  • Others
  • Low Vision Devices
  • Smart Glasses
  • VTS Link
  • Magnifying Lenses
  • Others
  • Others
• By End Users
  • Blind Schools & Training institutes
  • Enterprises & Social Organizations
  • Personal Use
  • Hospitals
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • OrCam Technologies
  • Freedom Scientific, Inc.
  • HumanWare Group
  • Enhanced Vision Systems (EVS)
  • Vispero
  • Eschenbach Optik GmbH
  • LVI Low Vision International
  • eSight Corporation
  • IrisVision
  • Rejoin Technology Co., Ltd
  • Zoomax Technology Co., Limited
  • Dolphin Computer Access Ltd
  • Aumed Group Corp.
  • Topcon Corporation
  • Microsoft Corporation
  • NovaVision, Inc.
  • Telesensory Corporation
  • Second Sight Medical Products, Inc.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Product Type
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Visual Impairment Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Visual Impairment Market, By Product Type, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Educational Devices & Software
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Braille Duplicators and Writers
• Braille Computers
• Mathematical & Science Devices
• Reading Machines
• Others
• Mobility Devices
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Canes
• Others
• Low Vision Devices
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Smart Glasses
• VTS Link
• Magnifying Lenses
• Others
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Visual Impairment Market, By End User, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Blind Schools & Training institutes
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Enterprises & Social Organizations
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Personal Use
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Hospitals
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Visual Impairment Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2021-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

8. Competitive Landscape

• Company Profiles
  • OrCam Technologies
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Sangamo Therapeutics, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Freedom Scientific, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • HumanWare Group
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Enhanced Vision Systems (EVS)
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Vispero
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Eschenbach Optik GmbH
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • LVI Low Vision International
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • eSight Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • IrisVision
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Rejoin Technology Co., Ltd
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Zoomax Technology Co., Limited
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Dolphin Computer Access Ltd
  • Aumed Group Corp.
  • Topcon Corporation
  • Microsoft Corporation
  • NovaVision, Inc.
  • Telesensory Corporation
  • Second Sight Medical Products, Inc.

9. Wheel of Fortune

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

10. Reference and Research Methodology

• References
• Research Methodology
• About us and Sales Contact